August 11, 2010 (Rockville, Maryland and York, Pennsylvania) — The Food and Drug Administration (FDA) has received more than 900 reports of adverse events with inferior vena cava (IVC) filters, ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

The large-scale PRESERVE trial is underway to evaluate the safety and effectiveness of inferior vena cava filters. As of mid-December, researchers have activated the first 10 medical sites and ...

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep blood clots ...

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

Unsealed court documents from lawsuits over inferior vena cava (IVC) filters expose a big gap between what manufacturers and regulators know about the safety of a medical device and how much of that ...

Deep vein thrombosis is a medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can ...

If you have had a deep vein thrombosis (DVT), you may worry about having another life-threatening clot. People who’ve had a DVT and can’t take blood-thinning medications have another option to prevent ...